Observational studyBMC nephrology2025
Predictors of time to remission in children with steroid-sensitive nephrotic syndrome: a prospective observational study in Nepal.
Observational study in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNephrotic syndrome is the most prevalent glomerular disease in children and corticosteroids are the mainstay of treatment. Although most children are steroid-sensitive, the response time varies. There is very limited research determining the factors that influence time to remission following steroid therapy. This study aims to identify predictors of time to remission in children with steroid-sensitive nephrotic syndrome (SSNS) at a tertiary level hospital in Nepal.
methodsA prospective observational study was conducted from June 2022 to May 2023 following ethical approval. Fifty-four children with SSNS aged 1–14 years were enrolled and prospectively followed with daily urine albumin dipstick test at home after initiating standard-dose steroid therapy until remission was achieved. The time to remission was recorded. Patients were categorized into early and late responder groups using a 9-day cut-off post-hoc. Independent student’s t-test, Mann-Whitney U test, fisher exact test and chi-square test were used to compare clinical and laboratory variables between groups.
resultsAmong 54 participants enrolled, 44 (81.5%) presented with a first episode and 10 (18.5%) with a relapse. The cohort had a male-to-female ratio of 2:1. The median age at onset was 5.0 years (IQR: 4.0, 9.0). The mean time to remission was 8.6 ± 1.7 days. Thirty-two (59.2%) participants were classified as early responders (< 9 days) and 22 (40.8%) as late responders (≥ 9 days). Remission was delayed in patients with hypertension and hematuria, although this trend was not statistically significant.
conclusionNone of the clinical variables (like age, gender, religion, geographical region, socioeconomic status, episode type (first episode/relapse), patient related factors like anemia, AKI, hypertension, ) and laboratory variables (like microscopic hematuria, raised serum creatinine, degree of hypoalbuminemia, hypercholesterolemia and severity of proteinuria) were significantly associated with time to remission in our analysis. This highlights the complexity of predicting steroid response and emphasizes the need for larger, multi-center studies to identify robust predictors of remission dynamics in pediatric nephrotic syndrome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.